MiRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines

Medical Oncology

Volumn 28, Issue 1, 2011, Pages 211-218

  Gu, Jingyi ^a   Zhu, Xuejiao ^a   Li, Yumin ^a   Dong, Dawei ^a   Yao, Junlin ^a   Lin, Chunyan ^a   Huang, Kangkang ^a   Hu, Haiyan ^a   Fei, Jia ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Antisense oligonucleotide; Apoptosis; Arsenic trioxide (ATO); Cell cycle; Chemosensitivity; Growth; HL60 Cells; K562 Cells; MiRNA 21; PDCD4

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARSENIC TRIOXIDE; MEMBRANE PROTEIN; MICRORNA 21; PROGRAMMED CELL DEATH PROTEIN 4; SMALL NUCLEAR RNA; TETRAZOLIUM; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ARSENICALS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MICRORNAS; OXIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 79952245224     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9413-7     Document Type: Article

References (40)

1. DP Bartel 2004 MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 281 297 14744438 10.1016/S0092-8674(04)00045-5 1:CAS:528: DC%2BD2cXhtVals7o%3D (Pubitemid 38167318)
2. L He GJ Hannon 2004 MicroRNAs: small RNAs with a big role in gene regulation Nat Rev Genet 5 522 531 15211354 10.1038/nrg1379 1:CAS:528: DC%2BD2cXltVSmsbw%3D (Pubitemid 38868508)
3. ZB Yu ZF Jian SH Shen 2007 Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos Nucleic Acids Res 35 152 164 17158157 10.1093/nar/gkl1032 1:CAS:528:DC%2BD2sXhtVyitr8%3D (Pubitemid 46189840)
4. S Griffiths-Jones RJ Grocock S van Dongen, et al. 2006 miRBase: MicroRNA sequences, targets and gene nomenclature Nucleic Acids Res 34 D140 D144 16381832 10.1093/nar/gkj112 1:CAS:528:DC%2BD28XisFyhtw%3D%3D
5. V Ambros 2004 The functions of animal microRNAs Nature 431 350 355 15372042 10.1038/nature02871 1:CAS:528:DC%2BD2cXnsFaiu7g%3D (Pubitemid 39265675)
6. PE Blower JH Chung JS Verducci 2008 MicroRNAs modulate the chemosensitivity of tumor cells Mol Cancer Ther 7 1 9 18187804 10.1158/1535-7163.MCT-07-0573 1:CAS:528:DC%2BD1cXmsVyiuw%3D%3D
7. E Salerno BJ Scaglione FD Coffman BD Brown A Baccarini H Fernandes G Marti ES Raveche 2009 Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity Mol Cancer Ther 8 9 268 292 10.1158/1535-7163.MCT-09-0127
8. H Zhu H Wu X Liu BR Evans DJ Medina 2008 Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells Biochem Pharmacol 76 582 588 18619946 10.1016/j.bcp.2008.06.007 1:CAS:528:DC%2BD1cXhtVSitbfN
9. T Boren Y Xiong A Hakam R Wenham S Apte G Chan SG Kamath DT Chen H Dressman JM Lancaster 2009 MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy Gynecol Oncol 113 2 249 255 19237188 10.1016/j.ygyno.2009.01.014 1:CAS:528:DC%2BD1MXktlygtLg%3D
10. Z Lu M Liu V Stribinskis 2008 MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene Oncogene 27 4373 4379 18372920 10.1038/onc.2008.72 1:CAS:528:DC%2BD1cXosFGitrw%3D (Pubitemid 352010003)
11. IA Asangani SA Rasheed DA Nikolova JH Leupold NH Colburn S Post H Allgayer 2008 MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer Oncogene 27 2128 2136 17968323 10.1038/sj.onc.1210856 1:CAS:528:DC%2BD1cXktFCnsrc%3D (Pubitemid 351485639)
12. Li SZ. The compendium of materia medica. Beijing: People's Medical Publishing House; 1982 (originally published in the Ming Dynasty of China, 1578).
13. SM Aronson 1994 Arsenic and old myths R I Med 77 233 234 7919541 1:STN:280:DyaK2M%2Fgtlaiug%3D%3D
14. HD Sun L Ma XC Hu TD Zhang 1992 Ai-lin 1 treated 32 cases of acute promyelocytic leukemia Chin J Integr Chin West Med 12 170 171
15. 3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients Blood 89 3354 3360 9129042 1:CAS:528:DyaK2sXivVymu7o%3D
16. C Niu H Yan T Yu HP Sun JX Liu XS Li, et al. 1999 Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients Blood 94 3315 3324 10552940 1:CAS:528: DyaK1MXnsVagtb0%3D (Pubitemid 29536124)
17. SL Soignet SR Frankel D Douer MS Tallman H Kantarjian E Calleja, et al. 2001 United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia J Clin Oncol 19 3852 3860 11559723 1:CAS:528: DC%2BD3MXnsVKqsbY%3D (Pubitemid 32880064)
18. QY Zhang JH Mao P Liu QH Huang J Lu YY Xie L Weng Y Zhang Q Chen SJ Chen Z Chen 2009 A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia Proc Natl Acad Sci USA 106 9 3378 3383 19208803 10.1073/pnas.0813142106 1:CAS:528: DC%2BD1MXivF2jsbs%3D
19. T Yin YL Wu HP Sun GL Sun YZ Du KK Wang J Zhang GQ Chen SJ Chen Z Chen 2004 Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein Blood 104 13 4219 4225 15339852 10.1182/blood-2004-04- 1433 1:CAS:528:DC%2BD2cXhtFaisr%2FE (Pubitemid 39625094)
20. Z Chen GQ Chen ZX Shen GL Sun JH Tong ZY Wang SJ Chen 2002 Expanding the use of arsenic trioxide: leukemias and beyond Semin Hematol 39 2 Suppl 1 22 26 12012319 10.1053/shem.2002.33611 1:CAS:528:DC%2BD38XksFSrtLs%3D (Review)
21. J Hu YF Liu CF Wu F Xu ZX Shen YM Zhu JM Li W Tang WL Zhao W Wu HP Sun QS Chen B Chen GB Zhou A Zelent S Waxman ZY Wang SJ Chen Z Chen 2009 Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia Proc Natl Acad Sci USA 106 9 3342 3347 19225113 10.1073/pnas.0813280106 1:CAS:528:DC%2BD1MXivF2jsLc%3D
22. V Mathews, et al. 2006 Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity Blood 107 2627 2632 16352810 10.1182/blood-2005-08-3532 1:CAS:528:DC%2BD28XjtlKltbs%3D
23. A Ghavamzadeh, et al. 2006 Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy Ann Oncol 17 131 134 16227315 10.1093/annonc/mdj019 1:STN:280:DC%2BD2MnntFKiug%3D%3D (Pubitemid 43033852)
24. S Gu L Jin F Zhang P Sarnow MA Kay 2009 Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs Nat Struct Mol Biol 16 2 144 150 19182800 10.1038/nsmb.1552 1:CAS:528: DC%2BD1MXht1egs70%3D (Epub 2009 Feb 1)
25. BP Lewis IH Shih MW Jones-Rhoades DP Bartel CB Burge 2003 Prediction of mammalian microRNA targets Cell 115 787 798 14697198 10.1016/S0092-8674(03) 01018-3 1:CAS:528:DC%2BD2cXhsFCnsw%3D%3D (Pubitemid 38058492)
26. J Manikandan JJ Aarthi SD Kumar PN Pushparaj 2008 Oncomirs: the potential role of non-coding microRNAs in understanding cancer Bioinformation 2 330 334 18685719
27. A Esquela-Kerscher FJ Slack 2006 Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 259 269 16557279 10.1038/nrc1840 1:CAS:528: DC%2BD28XivVyqtrs%3D
28. CC Esau 2008 Inhibition of microRNA with antisense oligonucleotides Methods 44 55 60 18158133 10.1016/j.ymeth.2007.11.001 1:CAS:528: DC%2BD2sXhsVOlsbnM (Pubitemid 350297990)
29. AM Cheng MW Byrom J Shelton 2005 Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis Nucleic Acids Res 33 1290 1297 15741182 10.1093/nar/gki200 1:CAS:528: DC%2BD2MXit1Knu7s%3D (Pubitemid 41439922)
30. J Weiler J Hunziker J Hall 2005 Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther 13 496 502 10.1038/sj.gt.3302654
31. B Lankat-Buttgereit R Göke 2009 The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation Biol Cell 101 6 309 317 19356152 10.1042/BC20080191 1:CAS:528:DC%2BD1MXktF2ktb4%3D
32. S Yekta IH Shih DP Bartel 2004 MicroRNA-directed cleavage of HOXB8 mRNA Science 304 594 596 15105502 10.1126/science.1097434 1:CAS:528: DC%2BD2cXjt1Crsr0%3D (Pubitemid 38541919)
33. S Bagga J Bracht S Hunter K Massirer J Holtz R Eachus AE Pasquinelli 2005 Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation Cell 122 553 563 16122423 10.1016/j.cell.2005.07.031 1:CAS:528:DC%2BD2MXpvVKntbw%3D (Pubitemid 41191154)
34. CY Chen D Zheng Z Xia AB Shyu 2009 Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps Nat Struct Mol Biol 16 11 1160 1166 19838187 10.1038/nsmb.1709 1:CAS:528:DC%2BD1MXht1OgsrzI (Epub 2009 Oct 18)
35. LB Frankel NR Christoffersen A Jacobsen M Lindow, et al. 2008 Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells J Biol Chem 283 1026 1033 17991735 10.1074/jbc.M707224200 1:CAS:528:DC%2BD1cXhsFaktw%3D%3D
36. M Fraser BM Leung X Yan HC Dan JQ Cheng BK Tsang 2003 Tsang. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells Cancer Res 63 7081 7088 14612499 1:CAS:528:DC%2BD3sXovVGlsLg%3D (Pubitemid 37413443)
37. M Fraser B Leung A Jahani-Asl X Yan WE Thompson BK Tsang 2003 Chemoresistance in human ovarian cancer: the role of apoptotic regulators Reprod Biol Endocrinol 1 66 14609433 10.1186/1477-7827-1-66 (Pubitemid 39130459)
38. J Li H Huang L Sun M Yang C Pan W Chen D Wu Z Lin C Zeng Y Yao P Zhang E Song 2009 MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor Clin Cancer Res 15 12 3998 4008 19509158 10.1158/1078-0432.CCR-08-3053 1:CAS:528:DC%2BD1MXntlOis7s%3D (Epub 2009 Jun 9)
39. AM Krichevsky G Gabriely 2009 miR-21: a small multi-faceted RNA J Cell Mol Med 13 1 39 53 19175699 10.1111/j.1582-4934.2008.00556.x 1:CAS:528:DC%2BD1MXjsVegurY%3D (Review)
40. SD Selcuklu MT Donoghue C Spillane 2009 miR-21 as a key regulator of oncogenic processes Biochem Soc Trans 37 Pt 4 918 925 19614619 10.1042/BST0370918 1:CAS:528:DC%2BD1MXovVOisrs%3D (Review)